EC 35 (Risedronate Sodium Delayed-Release 35 mg)
Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Actavis.
Risedronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for EC 35
Risedronate Sodium Delayed-Release
- Imprint
- EC 35
- Strength
- 35 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00591-3876 | Watson Pharmaceuticals, Inc. |
00430-0979 | Warner Chilcott |
Related Images for "EC 35"
More about risedronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 49 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.